Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
US10428017B2 · kind B2 · utility
0Cited by
2References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 22, 2018 |
| Grant date | Oct 1, 2019 |
| Priority date | — |
| Expiry date | Feb 22, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2602/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to compounds and their use in the treatment of cystic fibrosis, methods for their production, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compound of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.